Efpeglenatide: Research Status and Trial Data

What efpeglenatide is

Efpeglenatide is a compound that has been studied in clinical research but does not have an approved drug label. No indications, mechanism description, or brand names are available from regulatory labeling sources because none has been published for this compound.

Trial footprint

Efpeglenatide has been studied across 5 registered clinical trials. The available sample includes three phase 3 studies, all listed with a status of terminated. These trials examined efpeglenatide against placebo in people with type 2 diabetes mellitus who were inadequately controlled on basal insulin, with or without an oral antidiabetic drug, and separately in those inadequately controlled on metformin alone or combined with a sulfonylurea. A separate phase 3 trial examined the effect of efpeglenatide on cardiovascular outcomes. No efficacy or safety conclusions can be drawn from trial titles, phases, or status alone.